“Dexmedetomidine reduces ventilator-induced lung injury (VILI) by inhibiting Toll-like receptor 4 (TLR4)/nuclear factor (NF)-κB signaling pathway” (2018) Biomolecules and Biomedicine, 18(2), pp. 162–169. doi:10.17305/bjbms.2018.2400.